Thyroid Cancer Current Events | Thyroid Cancer News | 5
|
| Page
5 of
85 |
1684 Results |
|
|
|
Sort By:
Page Views | Date |
PROSTATE CANCER SERIES (p 859)
A four-week series about prostate cancer-the third most common cancer in men worldwide, and the leading male cancer in Europe and North America-begins in this week's issue of THE LANCET. The first article, by Henrik Grönberg of Umea University, Sweden, assesses the epidemiology of prostate cancer, and examines the impact of genetic and... view more... (2003-03-05)
New research finds some wood floor finishes are a likely source of PCB exposure
A case study to be published in the online open access journal Environmental Health suggests that old wood floor finishes in some homes may be an overlooked source of exposure to the now banned environmental pollutants polychlorinated biphenyls (PCBs). view more (2008-01-17)
Family history of breast cancer does not increase risk of womb cancer
A family history of breast cancer does not increase a woman`s chances of developing womb cancer, finds a 20-year study in the Journal of Medical Genetics. Cancers of the lining of the womb (endometrium) and breast share some of the same reproductive, hormonal, and lifestyle risk factors. The evidence for a genetic link between the two types of... view more... (2002-11-01)
Breast cancer drug receives FDA approval
A new use for the breast cancer drug Herceptin was approved by the FDA yesterday, a move that means more treatment options for the 25 percent of breast cancer patients with early-stage HER-2 positive breast cancer. view more (2006-11-20)
Chemotherapy and tamoxifen reduce risk of second breast cancer
Among breast cancer patients, both chemotherapy and tamoxifen independently reduced the risk of developing a second cancer in the other breast, according to a study published online December 25 in the Journal of the National Cancer Institute. The risk reduction persisted for at least 10 and 5 years, respectively. view more (2007-12-26)
Scans spot hidden tumors in rare cancer syndrome
Researchers at Dana-Farber Cancer Institute report that full-body PET/CT scanning detected unsuspected, treatable tumors in 3 of 15 patients with Li-Fraumeni syndrome (LFS), a rare genetic cancer syndrome for which no screening tests have been recommended. view more (2008-03-19)
Key mechanism found that promotes spread of malignant melanoma
Researchers at Northwestern University have discovered a key signaling mechanism that may promote the ability of highly aggressive malignant melanoma cells to metastasize, or spread from a primary tumor to distant sites within the body. view more (2005-11-01)
Women smokers have higher risk of lung cancer than men smokers, though lower lung cancer death rate
Women who smoke appear to be more susceptible to lung cancer than men who smoke, though women smokers have a lower rate of lung cancer-related death. view more (2006-07-12)
Increased ovarian cancer risk not found in women with breast cancer family history
Women with a strong family history of breast cancer but who don't have breast cancer genetic mutations can now be reassured that they are not at increased risk for ovarian cancer. view more (2005-09-21)
Nuclear medicine now safer than ever
Hospitals are now able to ensure that the correct dose is administered to the 670,000 patients that undergo nuclear medicine procedures every year due to a new device developed by scientists at the National Physical Laboratory (NPL). view more (2007-10-11)
Hydrogen peroxide marshals immune system
When you were a kid your mom poured it on your scraped finger to stave off infection. view more (2009-06-04)
Women without regular medical care at increased risk of ovarian cancer
In North America, ovarian cancer is the second most common gynecological cancer and is the leading cause of death among women with gynecological cancer. The high mortality is in part due to the difficulty of detecting and diagnosing this condition at an early stage. view more (2007-03-27)
Breast asymmetry predicts breast cancer
Women who go on to develop breast cancer tend to have breasts that are less symmetrical than women who don't develop the cancer. view more (2006-03-20)
Scientists Implicate Gene in Vitiligo and Other Autoimmune Diseases
In a study appearing in the March 22 New England Journal of Medicine, scientists supported by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) have discovered a connection between a specific gene and the inflammatory skin condition vitiligo, as well as a possible host of autoimmune... view more... (2007-04-11)
New gene silencing therapy for cervical cancer
Researchers at The University of Queensland's (UQ) Centre for Immunology and Cancer Research (CICR), based at the Princess Alexandra Hospital, have pioneered a new approach for the treatment of cervical cancer. view more (2005-11-17)
Increased levels of Muellerian-inhibiting substance could mean greater breast cancer risk
Women with increased levels of Müllerian inhibiting substance (MIS), best known for regulating in utero sexual differentiation in boys, may be at a greater risk for breast cancer. view more (2009-10-12)
Media Registration: Europe`s largest breast cancer conference to be held in Barcelona
3rd European Breast Cancer Conference (EBCC-3) Palau de Congressos de Catalunya, Barcelona, Spain 19-23 March 2002 ABOUT EBCC-3"¦ * More than 3000 clinicians, scientists and patient advocates will attend. * Presentations will review new developments in molecular biology, epidemiology, prevention, diagnosis, treatment, psycho-social... view more... (2001-12-04)
More children survive cancer but the after-effects present a challenge to doctors
Embargoed: 09.00 hrs CET Wednesday 24 September 2003 Copenhagen, Denmark: The number of children who survive childhood cancer is improving dramatically, but because of the side effects of their treatment the majority continue to need specialist care for many years. This rapid increase in the numbers of survivors means that the medical profession... view more... (2003-09-21)
Cancer Research UK supports additional TroVax phase II trial in colorectal cancer
Oxford BioMedica announced today that Cancer Research UK (CRUK) has agreed to conduct and sponsor an open label Phase II trial with Oxford BioMedica's leading cancer immunotherapy product, TroVax®, in colorectal cancer patients who have liver metastases. The decision by CRUK follows extensive review of the successful Phase I/II data of TroVax... view more... (2003-08-28)
Estrogen-progestin menopausal hormone therapy and risk of lobular and tubular breast cancer
Estrogen-progestin menopausal hormone therapy is associated with a more than two-fold higher relative risk of developing lobular cancer or tubular cancer than of developing ductal cancer. view more (2006-02-17)
|
|
| Page
5 of
85 |
1684 Results |
|
|
|
Sort By:
Page Views | Date |
|
